Billed as the “world’s smallest wearable stethoscope for patients,” the AeviceMD smart device can identify respiratory issues, including COPD and asthma, with continuous monitoring for abnormal lung sounds. Which could come in handy for lots of folks. The National Institutes of Health estimates that COPD affects about 15 million adults in America, and the Centers for Disease Control and Prevention (CDC) says that COPD is the fourth leading cause of death in the United States. The CDC estimates that 1 in 12 Americans (about 25 million people) have asthma.

So what does the device do? It measures the respiratory rate at rest in breaths per minute, and the heart rate in beats per minute. It can detect wheezes that may be signs that the wearer’s airways are narrowed or inflamed. Plus, cough detection and logging the frequency of coughs that could indicate a respiratory condition. The stethoscope’s embedded AI algorithms identify biomarkers of chronic respiratory disease and filter out ambient noise. Users can play back recorded sounds and share them with healthcare providers in real time. The stethoscope works for about 10 hours between charges.

To use the stethoscope, the user places the wireless sensor into a silicon patch and attaches it to an area of their chest, identifying the location with the aid of a connected app. The app offers advanced analytics and an overview of symptoms to help clinicians monitor patients with data that’s sent to the cloud via WiFi in real time. Through the app’s dashboard, one can track trends over time, including responses to treatment. If the stethoscope detects an issue, such as signs of exacerbation of symptoms, the app sends out an alert. The app can also send out medication reminders and has telehealth features that include video consultations with doctors and data sharing.

The winner of an Innovation Award at the recent CES 2023 expo, the smart stethoscope from the Singapore-based company Aevice Health is waiting for FDA clearance. When that happens, the company plans to bring the device to the U.S. market.